Scarica l'app Stockscreener
40.63
1.00%
-0.41
Precedente Chiudi:
$41.04
Aprire:
$41.04
Volume 24 ore:
22,638
Relative Volume:
0.37
Capitalizzazione di mercato:
$229.97M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.02%
1M Prestazione:
+1.15%
6M Prestazione:
-6.58%
1 anno Prestazione:
+1.58%
Intervallo 1D:
$40.49
$41.15
Intervallo di 1 settimana:
$40.26
$41.53
Portata 52W:
$35.22
$48.76
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
Nome
Spdr Pharmaceuticals Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta XPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XPH
Spdr Pharmaceuticals Etf
|
40.63 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
303.31 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
614.91 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
617.46 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
237.37 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
548.09 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf Borsa (XPH) Ultime notizie
Wealthcare Advisory Partners LLC Takes $339,000 Position in SPDR SSgA Ultra Short Term Bond ETF (NYSEARCA:ULST) - Defense World
Short bets on S&P 500 Healthcare sector ease in May; MRNA stays most shorted stock - Seeking Alpha
Kalkine Reports Surge in SPDR S&P 500 Pharma ETF Trading Activity - Kalkine Media
Cetera Investment Advisers Sells 718 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Ameriprise Financial Inc. Decreases Stock Position in SPDR S&P Bank ETF (NYSEARCA:KBE) - Defense World
2,299 Shares in SPDR S&P Aerospace & Defense ETF (NYSEARCA:XAR) Purchased by D. E. Shaw & Co. Inc. - Defense World
Invesco S&P 500 Pure Growth ETF (NYSEARCA:RPG) Stake Boosted by Ameriprise Financial Inc. - Defense World
D. E. Shaw & Co. Inc. Has $363,000 Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
D. E. Shaw & Co. Inc. Decreases Holdings in SPDR S&P 600 Small Cap Growth ETF (NYSEARCA:SLYG) - Defense World
Bank of America Corp DE Sells 22,425 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Trump Sparks New Chapter In Transatlantic Trade War: What The US Buys From Europe - Benzinga
Captrust Financial Advisors Increases Holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
SPDR S&P International Small Cap ETF (NYSEARCA:GWX) Shares Sold by Focus Partners Wealth - Defense World
1,953 Shares in SPDR S&P Semiconductor ETF (NYSEARCA:XSD) Acquired by Focus Partners Wealth - Defense World
US health authorities to set targets for lowering drug prices - Reuters
Here's How Trump Plans To Tackle Drug Prices, And Why It Might Not Work - inkl
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing DistortionCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Short bets against S&P 500 healthcare stocks climb in April; MRNA retains top shorted ranking - MSN
Stock ETFs Surge on China Tariffs Pact; Bonds, Gold Falter - Yahoo Finance
ETFs on the Move Post U.S.-China Trade Deal - Nasdaq
Pharma ETFs in Focus on Trump's Drug Price Overhaul - Yahoo Finance
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks - Benzinga
A Look at Pharma ETFs After Strong Q1 Earnings - Yahoo Finance
Raymond James Financial Inc. Invests $762,000 in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
SPDR S&P 400 Mid Cap Value ETF (NYSEARCA:MDYV) Shares Bought by Renaissance Technologies LLC - Defense World
Is Healthcare Losing the Status of Safe Haven? ETFs in Focus - TradingView
Best health care ETFs: Top biotech, pharma and medical funds - Bankrate
Russell Investments Group Ltd. Purchases 420 Shares of SPDR MSCI USA Gender Diversity Index ETF (NYSEARCA:SHE) - Defense World
Bank of Montreal Can Reduces Stock Position in SPDR S&P Semiconductor ETF (NYSEARCA:XSD) - Defense World
Bank of Montreal Can Decreases Stock Position in SPDR NYSE Technology ETF (NYSEARCA:XNTK) - Defense World
SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Shares Bought by JPMorgan Chase & Co. - Defense World
Wells Fargo & Company MN Increases Stock Position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Roche (RHHBY): Significant U.S. Investment to Enhance Manufacturing and Innovation - Value The Markets
Healthcare ETFs Tug of War: Insurers Tumble, Pharma Surges - TradingView
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot - Benzinga
UnitedHealth Woes Aren’t Dragging Down the Entire Sector. Here’s Why. - Barron's
6 Best Health Care Funds and ETFs for 2025 | Investing | U.S. News - Money/ US News
ETFs in Focus Post JNJ's Q1 Earnings Beat, Dividend Hike - TradingView
Top SA Quant-rated healthcare stocks as Q1 earnings unfold - Seeking Alpha
Tariffs threaten generic drug production and supplyFmr. FDA commissioner (XPH:NYSEARCA) - Seeking Alpha
Trump says pharma tariffs are coming soon (PPH:NASDAQ) - Seeking Alpha
National Bank of Canada FI Has $26,000 Holdings in SPDR Dow Jones International Real Estate ETF (NYSEARCA:RWX) - Defense World
Pharma, MedTech stocks bounce back as Trump pauses tariffs - MSN
Commonwealth Equity Services LLC Has $203,000 Holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies - Benzinga
A $576 Billion Stock-ETF Juggernaut Hit by Extreme Dislocations - Yahoo Finance
Pharma, MedTech stocks bounce back as Trump pauses most tariffs - Seeking Alpha
LPL Financial LLC Increases Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Raymond James Financial Inc. Makes New Investment in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Spdr Pharmaceuticals Etf Azioni (XPH) Dati Finanziari
Non sono disponibili dati finanziari per Spdr Pharmaceuticals Etf (XPH). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):